These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 30635021)

  • 1. The correlation between baseline score and post-intervention score, and its implications for statistical analysis.
    Clifton L; Clifton DA
    Trials; 2019 Jan; 20(1):43. PubMed ID: 30635021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sample size estimation for randomised controlled trials with repeated assessment of patient-reported outcomes: what correlation between baseline and follow-up outcomes should we assume?
    Walters SJ; Jacques RM; Dos Anjos Henriques-Cadby IB; Candlish J; Totton N; Xian MTS
    Trials; 2019 Sep; 20(1):566. PubMed ID: 31519202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing different ways of calculating sample size for two independent means: A worked example.
    Clifton L; Birks J; Clifton DA
    Contemp Clin Trials Commun; 2019 Mar; 13():100309. PubMed ID: 30582068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of percentage change from baseline as an outcome in a controlled trial is statistically inefficient: a simulation study.
    Vickers AJ
    BMC Med Res Methodol; 2001; 1():6. PubMed ID: 11459516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bias, precision and statistical power of analysis of covariance in the analysis of randomized trials with baseline imbalance: a simulation study.
    Egbewale BE; Lewis M; Sim J
    BMC Med Res Methodol; 2014 Apr; 14():49. PubMed ID: 24712304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-analysis of randomised trials with a continuous outcome according to baseline imbalance and availability of individual participant data.
    Riley RD; Kauser I; Bland M; Thijs L; Staessen JA; Wang J; Gueyffier F; Deeks JJ
    Stat Med; 2013 Jul; 32(16):2747-66. PubMed ID: 23303608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Covariate adjustment for randomized controlled trials revisited.
    Wang J
    Pharm Stat; 2020 May; 19(3):255-261. PubMed ID: 31863636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving the estimation of change from baseline in a continuous outcome measure in the clinical trial setting.
    Mayer-Hamblett N; Kronmal RA
    Contemp Clin Trials; 2005 Feb; 26(1):2-16. PubMed ID: 15837448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parametric versus non-parametric statistics in the analysis of randomized trials with non-normally distributed data.
    Vickers AJ
    BMC Med Res Methodol; 2005 Nov; 5():35. PubMed ID: 16269081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analyzing pre-post randomized studies with one post-randomization score using repeated measures and ANCOVA models.
    Wan F
    Stat Methods Med Res; 2019; 28(10-11):2952-2974. PubMed ID: 30084297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analysis of continuous outcomes: Using pseudo IPD created from aggregate data to adjust for baseline imbalance and assess treatment-by-baseline modification.
    Papadimitropoulou K; Stijnen T; Riley RD; Dekkers OM; le Cessie S
    Res Synth Methods; 2020 Nov; 11(6):780-794. PubMed ID: 32643264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-arm noninferiority trials with a prespecified margin for inference of the difference in the proportions of binary endpoints.
    Hida E; Tango T
    J Biopharm Stat; 2013; 23(4):774-89. PubMed ID: 23799810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimum number of clusters and comparison of analysis methods for cross sectional stepped wedge cluster randomised trials with binary outcomes: A simulation study.
    Barker D; D'Este C; Campbell MJ; McElduff P
    Trials; 2017 Mar; 18(1):119. PubMed ID: 28279222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Applications of Bayesian statistical methodology to clinical trial design: A case study of a phase 2 trial with an interim futility assessment in patients with knee osteoarthritis.
    Smith CL; Jin Y; Raddad E; McNearney TA; Ni X; Monteith D; Brown R; Deeg MA; Schnitzer T
    Pharm Stat; 2019 Jan; 18(1):39-53. PubMed ID: 30321909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The analysis of cross-over trials with baseline measurements.
    Metcalfe C
    Stat Med; 2010 Dec; 29(30):3211-8. PubMed ID: 21170915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Segmented Regression and Difference-in-Difference Methods: Assessing the Impact of Systemic Changes in Health Care.
    Mascha EJ; Sessler DI
    Anesth Analg; 2019 Aug; 129(2):618-633. PubMed ID: 31008746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A simple sample size formula for analysis of covariance in cluster randomized trials.
    Teerenstra S; Eldridge S; Graff M; de Hoop E; Borm GF
    Stat Med; 2012 Sep; 31(20):2169-78. PubMed ID: 22495809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regression to the Mean: A Commonly Overlooked and Misunderstood Factor Leading to Unjustified Conclusions in Pediatric Obesity Research.
    Cockrell Skinner A; Goldsby TU; Allison DB
    Child Obes; 2016 Apr; 12(2):155-8. PubMed ID: 26974388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Bayesian analysis of mortality outcomes in multicentre clinical trials in critical care.
    Sidebotham D; Popovich I; Lumley T
    Br J Anaesth; 2021 Sep; 127(3):487-494. PubMed ID: 34275603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statistical power for analyses of changes in randomized controlled trials.
    Tu YK; Blance A; Clerehugh V; Gilthorpe MS
    J Dent Res; 2005 Mar; 84(3):283-7. PubMed ID: 15723872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.